降低人工腎臟與血液迴路管凝固率方案

Reducing the Rate of Artificial Kidney and Blood Circuit TubingClotting Programmes

蕭美娟(Mei-Chuan Hslao)；陳慧瑛(Hui-Ying Chen)；劉嘉恩(Chia-En Liu)；游淑如(Shu-Ru Yu)

血液透析 ； 凝固 ； 凝固率 ； hemodialysis ； clotting ； clotting rate

若瑟醫護雜誌

9卷1期（2015 / 07 / 01）

35 - 49

繁體中文

本專案皆在降低透析人工腎臟與血液迴路管凝固率。在2011年第一季單位衛材盤點發現，每月人工腎臟平均耗費約多出25支、血液迴路管組多出45套，經查檢2011年6月人工腎臟與迴路管凝固率為11.09%。經特性要因分析找出問題有：血流不足、透析管路準備未依標準作業執行、人工腎臟材質、透析中未以生理食鹽水灌洗透析管路及抗凝劑劑量不足等五項。採行解決方案包括：透析評估及作業標準化、落實透析器及管路作業標準、護理指導病人每次透析前體重增加少於標準體重6%。專案改善後，除有效降低人工腎臟與迴路管凝固率至3.00%，更提高透析服務品質及增進病人安全，並減少每月耗材成本及廢棄物處置費用一萬四千元，增加醫院營收。

This project aims to reduce the rate of blood clotting hemodialysis artificial kidney and extracorporial blood circuit tubings. The result of the inventory audit in the first quarter of 2011 which was done during the month of June 2011 showed that, an average of about 25 sets of artificial kidney and 45 sets of blood circuit tubings consumed per month was found in excess by a rate of 11.09%. After thorough analysis, 5 important causes were found: inadequate blood flow, blood lines preparation which was not in accordance with standard technique, the quality of the artificial kidney material, intradialytic failure to flush with Normal saline. and the inadequate anticoagulation. The obtained solutions to these causes include: the evaluation and standardization of dialysis adequacy, implementation of dialyses and extracorporeal blood lines operating standards, educating the patient to limit the interdiaytic weight gain to less than 6% of his dry weight. After the improvements made, in addition to effectively reduced the clotting rate of artificial kidney and circuit tubing to 3%. it has improved the quality of dialysis services rendered as well as enhanced patient safety, and reduced the delivered cost and waste disposal expenses to 14,000NT per month, which inturn increase our hospital revenues.

1. Levy, J.,Morgan, J.,Brown, E.(2004).Oxford handbook of dialysis.New York:Oxford University Press.
2. Nissenson, AR. (ed.),Fine, R. N. (ed.)(2002).Dialysis Therapy.Philadelphia, PA:Hanley & Belfus.
3. 方靜玉,柯宣妤,林欲儒,黃育榛,官月萍,林莉蔡(2010)。人工腎臟凝固率之改善專案。臺灣腎臟護理學會雜誌，9(2)，45-58。
4. 向美玲,許自超(2011)。血液透析不足之探討。南台灣醫學雜誌，7(1)，64-69。
5. 呂嘉陞（編譯）,林建宇（編譯）,邱顯邦（編譯）(2006).透析治療臨床實證指引.台北:合記.
6. 李柏蒼(2005)。透析膜的特性與臨床應用。腎臟與透析，17(2)，123-125。
7. 陳秀惠,廖怜俞,陳麗琴,陳麗美(2010)。降低血液透析病人人工腎臟凝固率改善專案。北市醫學雜誌，7(1)，67-81。
8. 陳建文,吳柏青,田家榮,楊恩智,蕭善良(2008)。監測活化凝血時間提供血液透析病患安全合宜的肝素抗凝作用。腎臟與透析，20(4)，224-229。
9. 黃淑貞,李秀英,李秋妹,林其璘,柯昭子(2005)。降低人工腎臟凝固率專案。臺灣腎臟護理學會雜誌，4(1)，25-35。
10. 戴培惠,忻蘭,方雅蘭,詹碧端(2009)。降低某血液透析室生物醫療廢棄物重量。臺灣腎臟護理學會雜誌，8(1)，54-67。

1. 曾玉華,高玉貞,林懿如(2021)。降低血液透析過程人工腎臟凝固發生率之護理專案。臺灣腎臟護理學會雜誌，19(2)，35-48。